Skip to search formSkip to main contentSkip to account menu

Antibodies, Neutralizing

Known as: Neutralizing Antibodies, antibody neutralizing, Antibodies, Neutralizing [Chemical/Ingredient] 
Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a virus.
National Institutes of Health

Related topics

Related topics

18 relations

Narrower (10)

AVP-21D9BI 836845BIIB023CNTO 888

Broader (1)

Antibodies
Antibodies, BlockingAntibodies, ViralIn BloodNeutralising antibodies analysis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
Baby steps toward bNAbs Some HIV-infected individuals develop heavily mutated, broadly neutralizing antibodies (bNAbs) that… 
Highly Cited
2014
Highly Cited
2014
Rapid development of broadly influenza neutralizing antibodies through redundant mutations
The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin… 
Highly Cited
2013
Highly Cited
2013
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
A desirable but as yet unachieved property of a human immunodeficiency virus type 1 (HIV-1) vaccine candidate is the ability to… 
Highly Cited
2010
Highly Cited
2010
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals
Background The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-1 isolates and the… 
Highly Cited
2009
Highly Cited
2009
A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates
Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates serum LDL cholesterol (LDL-C) by interacting with the LDL… 
Highly Cited
2005
Highly Cited
2005
Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.
Human antibody 2G12 neutralizes a broad range of HIV-1 isolates. Hence, molecular characterization of its epitope, which… 
Highly Cited
2002
Highly Cited
2002
Identification of Neutralizing and Nonneutralizing Epitopes in the Porcine Reproductive and Respiratory Syndrome Virus GP5 Ectodomain
After infection of swine with porcine reproductive and respiratory syndrome virus (PRRSV), there is a rapid rise of PRRSV… 
Highly Cited
1999
Highly Cited
1999
PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo.
Replication-defective recombinant adenovirus (Ad) vectors are under development for a wide variety of gene therapy indications. A… 
Highly Cited
1999
Highly Cited
1999
Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection
ABSTRACT The activity of antibodies against filoviruses is poorly understood but has important consequences for vaccine design… 
Highly Cited
1989
Highly Cited
1989
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
The principal neutralizing determinant of human immunodeficiency virus type 1 (HIV-1) is located in the external envelope protein… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)